Boston Scientific

Boston Scientific (BSX) stock slips in year-end pullback; February earnings loom

NEW YORK, December 29, 2025, 10:27 PM ET — Market closed Boston Scientific shares closed down 0.3% at $95.76 on Monday. The stock traded between $95.53 and $96.64, with about 5.4 million shares changing hands. StockAnalysis The modest move still

30 December 2025

Boston Scientific (BSX) Stock After Hours on Dec. 24, 2025: Key Moves, Today’s Fresh Analysis, and What to Watch Before Markets Reopen

Boston Scientific Corporation (NYSE: BSX) wrapped up a holiday-shortened Christmas Eve session with a modest move in regular trading — and a small uptick in after-hours. With U.S. markets closed on Christmas Day (Dec. 25) and set to reopen Friday

25 December 2025

After Hours Trading · Financial Analysis · Investment Strategies · Market News · NYSE:BSX · Stock Market

Boston Scientific (BSX) Stock News Today: UBS Reiterates $140 Target as Valuation Debate Intensifies on Dec. 19, 2025

Boston Scientific Corporation (NYSE: BSX) stock is trading lower in Friday’s session, with shares at $95.76 as of 17:30 UTC on December 19, 2025 (down 0.36% on the day). The stock’s intraday range has run from $95.64 to $97.24, after

19 December 2025

Company Analysis · Financial Updates · Healthcare Stocks · Investment News · NYSE:BSX · Stock Market

Boston Scientific (BSX) Stock After Hours Dec. 18, 2025: Analyst Targets Shift, Options Point to Key Levels, and What to Watch Before Friday’s Open

Boston Scientific Corporation (NYSE: BSX) finished Thursday’s session (December 18, 2025) on a strong note, and early after-hours trading was notably calm—an important tell for investors heading into Friday’s open (December 19). Shares closed at $96.11, up 1.73%, marking a

19 December 2025

Analyst Ratings · Financial News · Investing · NYSE:BSX · Options Trading · Stock Market

Boston Scientific (BSX) Stock After Hours on Dec. 17, 2025: Analysts Stay Bullish as Shares Close Higher — What to Watch Before Thursday’s Open

Boston Scientific Corporation (NYSE: BSX) ended Wednesday, December 17, 2025, in positive territory even as the broader market sold off. The medical-device maker’s shares closed up 1.65% at $94.48, extending gains for a second session and outperforming several large medtech

18 December 2025

After Hours Trading · Analyst Ratings · Financial News · Investing · NYSE:BSX · Stock Market

Boston Scientific (BSX) Stock News Today: UBS Reiterates $140 Target, RBC Raises to $130 as 2026 Catalysts Come Into Focus

Boston Scientific Corporation (NYSE: BSX) is back in the spotlight on Wednesday, December 17, 2025, as fresh Wall Street commentary and a new round of target-price updates reframe the conversation around the medtech leader’s 2026 setup—especially in fast-growing cardiac categories

17 December 2025

Analyst Ratings · Financial News · Investing · Medical Technology · Stock Market

Boston Scientific (BSX) Stock News on Dec. 16, 2025: Price Action, Analyst Forecasts, and What Investors Are Watching

Boston Scientific Corporation (NYSE: BSX) is back in the spotlight on Tuesday, December 16, 2025, as the stock trades in the low-$90s—well below its September highs—while Wall Street’s broader view remains notably upbeat on the medical-device leader’s growth outlook. As

16 December 2025

Analyst Forecasts · Financial News · Healthcare Stocks · Investment Analysis · NYSE:BSX · Stock Market

Boston Scientific (BSX) Stock on December 10, 2025: Why Shares Are Sliding While the Growth Story Stays Intact

Boston Scientific Corporation (NYSE: BSX) is having a rough early December on the stock market—even as its earnings, pipeline and analyst forecasts remain firmly bullish. As of December 10, 2025, Boston Scientific stock is trading around $92.5 per share, roughly

10 December 2025

Company News · Financial Analysis · Growth Stocks · Investing · NYSE:BSX · Stock Market

Boston Scientific (BSX) Extends Losing Streak: What Tuesday’s Close Means Before the Bell on December 10, 2025

Boston Scientific Corporation (NYSE: BSX) heads into Wednesday’s U.S. trading session looking bruised but far from broken. On Tuesday, December 9, 2025, Boston Scientific stock slipped about 1.4% to roughly $92.5 per share, on heavier‑than‑usual volume of around 12.7 million

10 December 2025

Company Analysis · Financial News · Investing · Market Trends · Stock Market

Boston Scientific Stock (BSX) on December 3, 2025: Insider Sales, EU Device Win and Strong 2026 Price Targets

December 3, 2025 – Market close snapshot and latest news for Boston Scientific Corporation (NYSE: BSX). Boston Scientific Corporation stock remains a closely watched name in large‑cap medical technology as 2025 winds down. On December 3, 2025, the BSX share

4 December 2025

Financial News · Insider Trading · Investment Analysis · Medical Devices · NYSE:BSX · Stock Market

Boston Scientific Stock Rockets on Blowout Q3 Results and Major Medical Wins

Boston Scientific (BSX) Stock Today: Price Slips as Neuromodulation Bull Case, Epic EHR Deal and Big Fund Moves Shape the Outlook – November 19, 2025

Boston Scientific Corporation (NYSE: BSX) shares traded lower on Wednesday, November 19, 2025, even as a wave of fresh research, strategic partnership news and institutional ownership updates painted a largely constructive long‑term picture for the medtech giant. BSX stock price

19 November 2025

Company News · Healthcare Investments · Market Trends · Medical Technology · NYSE:BSX · Stock Analysis

Boston Scientific Stock Rockets on Blowout Q3 Results and Major Medical Wins

Boston Scientific’s Q3 report blew past expectations. Marlborough, MA-based Boston Scientific (NYSE:BSX) posted reported net income of $755 M ($0.51/share GAAP) and adjusted EPS of $0.75 timesunion.com chartmill.com, topping the $0.71–$0.72 analysts’ forecast. CEO Mike Mahoney called it “another exceptional quarter

22 October 2025

Earnings Reports · Investing · Market News · Medical Technology · Stocks